Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable data in clinical trials for size loss . It works by targeting several pathways : GLP-1 and GIP, https://lexieuwfv674984.activosblog.com/39398881/a-new-possibility-for-body-loss